Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

SNDL Inc.

SNDLNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.49
$-0.09(-5.70%)
U.S. Market opens in 15h 29m

SNDL Inc. (SNDL) Stock Overview

Explore SNDL Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap383.7M
P/E Ratio-6.03
EPS (TTM)$-0.26
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$1.10
3 Months$1.83
1 Year Target$2.06

SNDL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SNDL Inc. (SNDL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.16, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.06.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.03 and a market capitalization of 383.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.70%
5-Day Change
N/A
1-Month Change
-9.15%
3-Month Change
-7.45%
6-Month Change
-33.78%
Year-to-Date (YTD) Change
-14.37%
1-Year Change
-10.78%
3-Year Change
-25.87%
5-Year Change
-88.17%
All-Time (Max) Change
-98.24%

Contact Information

14039485227
919–11 Avenue SW, Calgary, AB, T2R 1P3

Company Facts

26,040 Employees
IPO DateAug 1, 2019
CountryCA
Actively Trading

Frequently Asked Questions